These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28222044)

  • 21. Minimal modeling of insulin secretion in the perfused rat pancreas: a drug effect case study.
    Riz M; Pedersen MG; Toffolo GM; Haschke G; Schneider HC; Klabunde T; Margerie D; Cobelli C
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E627-34. PubMed ID: 24425760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Synergy of Glucose and GLP-1 to Stimulate Insulin Secretion Revealed by Quantitative Phosphoproteomics.
    Tang JS; Li QR; Li JM; Wu JR; Zeng R
    Sci Rep; 2017 Apr; 7(1):1018. PubMed ID: 28432305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular glucose availability and glucagon-like peptide-1.
    Park JH; Earm YE; Song DK
    Prog Biophys Mol Biol; 2011 Nov; 107(2):286-92. PubMed ID: 21907232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic-derived factor impaired glucagon-like Peptide-1 production from GLUTag enterendorine L-cell line and intestines.
    Lai F; Chen Y; Lin H; Wang X; Zhu X; Li Y; Xiao H; Cao X
    Mol Cell Endocrinol; 2017 Sep; 452():110-119. PubMed ID: 28549991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
    Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
    BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
    Vasu S; Moffett RC; McCluskey JT; Hamid MH; Irwin N; Flatt PR
    Gene Ther; 2013 Nov; 20(11):1077-84. PubMed ID: 23784442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
    McClenaghan NH; Flatt PR; Ball AJ
    J Endocrinol; 2006 Sep; 190(3):889-96. PubMed ID: 17003289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
    Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
    Lam NT; Kieffer TJ
    Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupted dynamics of F-actin and insulin granule fusion in INS-1 832/13 beta-cells exposed to glucotoxicity: partial restoration by glucagon-like peptide 1.
    Quinault A; Gausseres B; Bailbe D; Chebbah N; Portha B; Movassat J; Tourrel-Cuzin C
    Biochim Biophys Acta; 2016 Aug; 1862(8):1401-11. PubMed ID: 27101990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge.
    Dalla Man C; Micheletto F; Sathananthan M; Vella A; Cobelli C
    Diabetes Technol Ther; 2016 Jan; 18(1):39-46. PubMed ID: 26756104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1.
    Green BD; Liu HK; McCluskey JT; Duffy NA; O'Harte FP; McClenaghan NH; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):563-9. PubMed ID: 16050949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
    Lee YS; Jun HS
    Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
    Lee S; Youn YS; Lee SH; Byun Y; Lee KC
    Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The insulinotropic effect of exogenous glucagon-like peptide-1 is not affected by acute vagotomy in anaesthetized pigs.
    Veedfald S; Hansen M; Christensen LW; Larsen SA; Hjøllund KR; Plamboeck A; Hartmann B; Deacon CF; Holst JJ
    Exp Physiol; 2016 Jul; 101(7):895-912. PubMed ID: 27027735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
    Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
    Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.